A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction-Reference-Cited by-同舟云学术

A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction

Published:2015-03 Issue:3 Volume:193 Page:921-926
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Ichihara Koji¹,Masumori Naoya¹,Fukuta Fumimasa¹,Tsukamoto Taiji¹,Iwasawa Akihiko²,Tanaka Yoshinori³

Affiliation:

1. Department of Urology, Sapporo Medical University School of Medicine, Hokkaido, Japan

2. Iwasawa Clinic, Hokkaido, Japan

3. Department of Urology, Hokkaido Prefectural Esashi Hospital, Hokkaido, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;Oelke;Eur Urol,2013

2. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder;Lee;BJU Int,2004

3. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers;Chapple;Eur Urol,2009

4. Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency;Kaplan;J Urol,2009

5. Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms–ASSIST, randomized controlled study;Yamaguchi;Urology,2011

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

2. Safety and efficacy of an α₁‐blocker plus mirabegron compared with an α₁‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis;Neurourology and Urodynamics;2024-01-30

3. Mirabegron Add-On Tamsulosin for Men with Overactive Bladder Symptoms: A Pooled Analysis of Four Randomized Controlled Trials;Urologia Internationalis;2024

4. Drug–Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly;Pharmaceuticals;2023-10-13

5. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients – a network meta-analysis;BMC Urology;2023-10-03